Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
The Journal of Invasive Cardiology|November 8, 2007
Isolated disease of the ostium left anterior descending or circumflex artery: management using a left main stenting technique. Clinical outcome at 2 yearsRoberto J Cubeddu, Frances O Wood, Elizabeth K Saylors, et al.
The American Journal of Cardiology|June 17, 2011
Systemic hypothermia to prevent radiocontrast nephropathy (from the COOL-RCN Randomized Trial)Gregg W Stone, Kishor Vora, John Schindler, et al.
JAMA|November 19, 2002
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trialSteven R Steinhubl, Peter B Berger, J Tift Mann, et al.
The American Journal of Cardiology|May 18, 2012
Meta-analysis comparing bivalirudin versus heparin monotherapy on ischemic and bleeding outcomes after percutaneous coronary interventionOlivier F Bertrand, Sanjit S Jolly, Sunil V Rao, et al.
The American Journal of Cardiology|September 2, 1998
Effect of direct thrombin inhibition with Bivalirudin (Hirulog) on restenosis after coronary angioplastyJ E Burchenal, D S Marks, J Tift Mann, et al.
JACC. Cardiovascular Interventions|October 23, 2010
Transradial approach for coronary angiography and interventions: results of the first international transradial practice surveyOlivier F Bertrand, Sunil V Rao, Samir Pancholy, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 26, 2003
Coronary stenting in stable patients: identification of a low-risk subgroup that may not require adjunctive antiplatelet therapyTift Mann, Roberto J Cubeddu, Laura Raynor, et al.
The American Journal of Cardiology|August 2, 2011
Propensity-matched patient-level comparison of the TAXUS Liberté and TAXUS element (ION) paclitaxel-eluting stentsDean J Kereiakes, Louis A Cannon, John A Ormiston, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 8, 2006
Pivotal, randomized U.S. study of the Symbiottrade mark covered stent system in patients with saphenous vein graft disease: eight-month angiographic and clinical results from the Symbiot III trialMark A Turco, Maurice Buchbinder, Jeffrey J Popma, et al.
Journal of Interventional Cardiology|July 14, 2010
Protected carotid stenting in high-risk patients: results of the SpideRX arm of the carotid revascularization with ev3 arterial technology evolution trialRobert D Safian, Michael R Jaff, John F Bresnahan, et al.
Pageof 5